查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553512

經導管肺動脈瓣市場規模、佔有率、趨勢分析報告：按應用、按技術、按最終用途、按原料、按地區、細分市場預測，2024-2030年

Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report By Application (Pulmonary Stenosis, Pulmonary Regurgitation), By Technology, By End-use, By Raw Material, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

經導管肺動脈瓣市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球經導管肺動脈瓣市場規模將達到1.006億美元，2024年至2030年複合年成長率為5.5%。

心臟瓣膜技術的技術進步、各種上市和私人公司臨床試驗管道的增加是預計在預測期內推動市場發展的一些關鍵因素。

2023年，北美將佔據全球大部分市場佔有率，約80.6%。主要促進因素包括各種心血管疾病的盛行率不斷增加、患有心臟瓣膜疾病（如肺動脈瓣狹窄、肺動脈瓣逆流）的老年人口不斷增加，以及人們對經導管瓣膜相對於外科手術的優勢的認知不斷增加。患有長期心臟病的患者數量不斷增加，對技術先進的心臟瓣膜的認知不斷提高，以及整體經導管瓣膜的醫療支出和報銷政策的增加是推動全球市場成長的主要因素。

然而，由於計劃推出多項產品，預計從 2019 年起，亞太地區該市場將出現成長。由於日本和中國等許多新興經濟體的成長，亞太地區預計將以良好的成長率成長。由於人口老化和心臟病盛行率上升等多種因素，這些新興國家展現出成長潛力。此外，大量患者的存在、醫療基礎設施和服務的發展、可支配收入的增加、政府資金的增加等都是預計在預測期內推動市場的一些因素。

經導管肺動脈瓣市場報告亮點

  • 肺動脈狹窄在市場上佔據主導地位，2023年市場佔有率為43.1%。 TPV 手術比心臟直視手術侵入性更小。
  • 2023年，球囊型經導管瓣膜細分市場佔據大部分收益佔有率，經導管肺動脈瓣市場預計在預測期內成長最快。
  • 主要企業包括 Boston Scientific Corporation、Braile Biomedica、Direct Flow Medical、Edwards Lifesciences Corporation、JenaValve Technology, Inc.、St. Jude Medical 和 VENUS MEDTECH。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 經導管肺動脈瓣市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 經導管肺動脈瓣市場分析工具
    • 波特的分析
    • PESTEL分析

第4章經導管肺動脈瓣市場：應用估算與趨勢分析

  • 細分儀表板
  • 經導管肺動脈瓣市場：2023 年和 2030 年應用變化分析
  • 肺動脈狹窄
  • 肺逆流症
  • 肺動脈閉鎖
  • 其他

第5章經導管肺動脈瓣市場：技術評估與趨勢分析

  • 細分儀表板
  • 經導管肺動脈瓣市場：2023 年和 2030 年技術變化分析
  • 球囊擴張經導管瓣膜
  • 自膨脹式經導管瓣膜

第6章經導管肺動脈瓣市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 經導管肺動脈瓣市場：2023 年和 2030 年最終用途變化分析
  • 成人
  • 兒科經導管瓣膜

第7章經導管肺動脈瓣市場：原料估算與趨勢分析

  • 細分儀表板
  • 經導管肺動脈瓣市場：2023年及2030年原料變化分析
  • 合成
  • 組織工程

第8章經導管肺動脈瓣市場：區域估計和趨勢分析

  • 2023年及2030年經導管肺動脈瓣市場佔有率（按地區），百萬美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Boston Scientific Corporation
    • Braile Biomedica
    • Artivion, Inc
    • Edwards Lifesciences Corporation
    • JenaValve Technology, Inc.
    • LivaNova PLC
    • Medtronic
    • Venus Medtech
    • Lepu Medical Technology
    • Jude Medical Inc.
簡介目錄
Product Code: GVR-1-68038-702-5

Transcatheter Pulmonary Valve Market Growth & Trends:

The global transcatheter pulmonary valve market size is expected to reach USD 100.6 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.

In 2023, North America held the majority of market share of nearly 80.6% in the global market. Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures. The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.

However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region. The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China. These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases. Moreover, the presence of a large pool of patients, developing healthcare infrastructure & services, increasing disposable income, and rising government funding are some of the factors that are expected to drive the market during the forecast period.

Transcatheter Pulmonary Valve Market Report Highlights:

  • Pulmonary stenosis dominated the market and accounted for a market share of 43.1% in 2023. TPV operations are less invasive in nature compared to open-heart surgery.
  • In 2023, balloon transcatheter valve segment held majority of the revenue share and is expected to be the fastest growing transcatheter pulmonary valve market during the forecast period
  • Some of the key players are Boston Scientific Corporation, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., St. Jude Medical, and VENUS MEDTECH.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Pulmonary Valve Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Transcatheter Pulmonary Valve Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Transcatheter Pulmonary Valve Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transcatheter Pulmonary Valve Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Pulmonary Stenosis
    • 4.3.1. Pulmonary Stenosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Pulmonary Regurgitation
    • 4.4.1. Pulmonary Regurgitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pulmonary Atresia
    • 4.5.1. Pulmonary Atresia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transcatheter Pulmonary Valve Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transcatheter Pulmonary Valve Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Ballon Expanded Transcatheter Valve
    • 5.3.1. Ballon Expanded Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Self Expanded Transcatheter Valve
    • 5.4.1. Self Expanded Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transcatheter Pulmonary Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transcatheter Pulmonary Valve Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Adult
    • 6.3.1. Adult Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pediatric Transcatheter Valve
    • 6.4.1. Pediatric Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transcatheter Pulmonary Valve Market: Raw Material Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Transcatheter Pulmonary Valve Market: Raw Material Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Synthetic
    • 7.3.1. Synthetic Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Tissue engineered
    • 7.4.1. Tissue engineered Transcatheter Valve Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transcatheter Pulmonary Valve Market: Regional Estimates & Trend Analysis

  • 8.1. Transcatheter Pulmonary Valve Market Share, By Region, 2023 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Sweden Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Boston Scientific Corporation
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Braile Biomedica
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Artivion, Inc
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Edwards Lifesciences Corporation
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. JenaValve Technology, Inc.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. LivaNova PLC
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Medtronic
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Venus Medtech
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Lepu Medical Technology
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Jude Medical Inc.
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives